rs148698911
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_001206927.2(DNAH8):āc.7471A>Gā(p.Ile2491Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000275 in 1,613,520 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001206927.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH8 | NM_001206927.2 | c.7471A>G | p.Ile2491Val | missense_variant | 51/93 | ENST00000327475.11 | NP_001193856.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH8 | ENST00000327475.11 | c.7471A>G | p.Ile2491Val | missense_variant | 51/93 | 5 | NM_001206927.2 | ENSP00000333363.7 | ||
DNAH8 | ENST00000359357.7 | c.6820A>G | p.Ile2274Val | missense_variant | 49/91 | 2 | ENSP00000352312.3 | |||
DNAH8 | ENST00000449981.6 | c.7471A>G | p.Ile2491Val | missense_variant | 50/82 | 5 | ENSP00000415331.2 |
Frequencies
GnomAD3 genomes AF: 0.000959 AC: 146AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000328 AC: 82AN: 250318Hom.: 0 AF XY: 0.000251 AC XY: 34AN XY: 135336
GnomAD4 exome AF: 0.000204 AC: 298AN: 1461228Hom.: 1 Cov.: 34 AF XY: 0.000186 AC XY: 135AN XY: 726972
GnomAD4 genome AF: 0.000959 AC: 146AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.00113 AC XY: 84AN XY: 74472
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Spermatogenic failure 46 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 04, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at